Total Funding
43
46
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
102942
SpineThera is a pharmaceutical company that develops novel, sustained-release, and injectable drugs to treat pain.
Jeff Missling: Founder and CEO
William Houghton: Chief Medical OfficerPast Role: Clene Nanomedicine, Chief Medical Officer
About the Company
SpineThera develops novel, sustained-release, injectable drugs to treat pain; offering patients and physicians alternatives that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
It was founded in 2012 and is headquartered in Plymouth, Minnesota.
